SOLACI-CACI 2021 | Day 3: Andreas Grüentzig Auditorium – Pediatric Sessions

✔️ Day 3, SOLACI-CACI 2021.
✔️ Andreas Gruentzig Auditorium.

👨‍🏫 Program:

  • 00:05 – Current Status of Hybrid Interventions in Congenital Heart Disease
  • 01:35:43 – Radiation Protection: Are We Doing Enough?
  • 02:59:48 – Oral presentation
  • 04:14:06 – Oral presentation
  • 05:44:16 – Fetal, Neonatal and Expanding Limits Interventions.

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

SOLACI-CACI 2021 | Day 1: Main Arena Auditorium

✔️ Day 1, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 06:20 - TCT@SOLACI-CACI 2021 Session - "The Future of PCI" 01:33:19 - PCR@SOLACI-CACI 2021 Session 👉...

SOLACI-CACI 2021 | Day 2: Main Arena Auditorium

✔️ Day 2, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:01 - TCT@SOLACI-CACI 2021 Session: "Structural Heart Interventions" 01:30:26 - CRT@SOLACI-CACI 2021 Session 02:51:13 - Oral...

SOLACI-CACI 2021 | Day 3: Main Arena Auditorium

✔️ Day 3 Completo, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:05 - CBS@SOLACI-CACI Session 01:43:26 - CCI@SOLACI-CACI Session 03:07:38 - Oral presentation – Structural III 04:32:21 -...

SOLACI-CACI 2021 | Day 4: Main Arena Auditorium

✔️ Day 4, SOLACI-CACI 2021 ✔️ Main Arena Auditorium 👨‍🏫 Program: 00:09 - The MIL Group/SOLACI/CACI/WAO Gender Opportunities in Interventional Cardiology 01:30:55 - Current and Immediate...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...